Early monitoring of response to neoadjuvant chemotherapy in breast cancer with 18F-FDG PET/CT: defining a clinical aim

Eur J Nucl Med Mol Imaging. 2011 Mar;38(3):419-25. doi: 10.1007/s00259-010-1660-5.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Breast Neoplasms / diagnosis*
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / therapy*
  • Clinical Trials as Topic
  • Fluorodeoxyglucose F18*
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Neoadjuvant Therapy*
  • Positron-Emission Tomography / methods*
  • Positron-Emission Tomography / standards
  • Receptor, ErbB-2 / metabolism
  • Receptors, Estrogen / metabolism
  • Reference Standards
  • Time Factors
  • Tomography, X-Ray Computed / methods*
  • Tomography, X-Ray Computed / standards
  • Treatment Outcome

Substances

  • Receptors, Estrogen
  • Fluorodeoxyglucose F18
  • ERBB2 protein, human
  • Receptor, ErbB-2